| P50 | author | Alexander Muacevic | Q47460834 |
| P2093 | author name string | Anand Mahadevan | |
| | Takuma Nomiya | |
| | Hiroshi Onishi | |
| | Bin S Teh | |
| | Michael Staehler | |
| | Simon S Lo | |
| | Alexander Muacevic | |
| | Rodney J Ellis | |
| | Shankar Siva | |
| | Peter Wersall | |
| | Lee Ponsky | |
| P2860 | cites work | Comparison of rates and risk factors for developing chronic renal insufficiency, proteinuria and metabolic acidosis after radical or partial nephrectomy | Q46120668 |
| | Single fraction radiosurgery for the treatment of renal tumors. | Q51054482 |
| | Percutaneous CT-guided radiofrequency ablation of renal neoplasms: factors influencing success. | Q53620215 |
| | Combining radiotherapy and cancer immunotherapy: a paradigm shift | Q27021428 |
| | Global cancer statistics, 2012 | Q27860501 |
| | Cancer statistics, 2013 | Q27860762 |
| | New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) | Q28131668 |
| | Cryoablation or radiofrequency ablation of the small renal mass : a meta-analysis | Q30437879 |
| | Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials | Q30656342 |
| | Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial | Q34518062 |
| | Stereotactic ablative body radiation therapy for primary kidney cancer: a 3-dimensional conformal technique associated with low rates of early toxicity | Q35466044 |
| | Stereotactic body radiation therapy: a novel treatment modality | Q37649474 |
| | The role of radiologic imaging and biopsy in renal tumor ablation | Q37737120 |
| | Contrast enhancement on computed tomography after renal cryoablation: an evidence of treatment failure? | Q37954371 |
| | Comparative effectiveness for survival and renal function of partial and radical nephrectomy for localized renal tumors: a systematic review and meta-analysis | Q38010568 |
| | A systematic review of stereotactic radiotherapy ablation for primary renal cell carcinoma | Q38056219 |
| | Abscopal effects of radiation therapy: a clinical review for the radiobiologist | Q38152541 |
| | Extracranial oligometastatic renal cell carcinoma: current management and future directions. | Q38209605 |
| | Routine prostate biopsies following radiotherapy for prostate cancer: results for 226 patients | Q40506672 |
| | Computed Tomography Contrast Enhancement Following Renal Cryoablation--Does it Represent Treatment Failure? | Q40758415 |
| | Phase I dose-escalation study of stereotactic body radiotherapy (SBRT) for poor surgical candidates with localized renal cell carcinoma | Q41370077 |
| | Tumor response, toxicity, and survival after neoadjuvant organ-preserving chemotherapy for advanced laryngeal carcinoma. The Department of Veterans Affairs Cooperative Laryngeal Cancer Study Group | Q45335973 |
| | Chronic kidney disease due to surgical removal of nephrons: relative rates of progression and survival | Q45762478 |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 637-645 | |
| P577 | publication date | 2016-02-03 | |
| P1433 | published in | Future Oncology | Q2781597 |
| P1476 | title | Consensus statement from the International Radiosurgery Oncology Consortium for Kidney for primary renal cell carcinoma | |
| P478 | volume | 12 | |